Theory of Living Systems Webinar - Prof. John Glass (J. Craig Venter Institute) - 13/12/2023
Title: Design, Construction, and Analysis of a Synthetic Minimal Bacterial Cell Abstract: The minimal cell is the hydrogen atom of cellular biology. Such a cell, because of its simplicity and absence of redundancy would be a platform for investigating just what biological components are required for life, and how those parts work together to make a living cell. Since the late 1990s, our team at the Venter Institute has been developing a suite of synthetic biology tools that enabled us to build what previously has only been imagined, a minimal cell. Specifically, a bacterial cell with a genome that expresses only the minimum set of genes needed for the cell to divide every two hours that can be grown in pure culture. That minimal cell has about half of the genes that are in the bacterium on which it was based, Mycoplasma mycoides JCVI syn1.0, the so-called synthetic bacteria we reported on in 2010. We used transposon bombardment to identify non-essential genes, and genes needed to maintain rapid growth in M. mycoides. Those findings required re-design and re-synthesis of some reduced genome segments. Three cycles of design, synthesis, and testing, with retention of quasi‐essential genes, produced synthetic bacterium JCVI‐Syn3.0 (531 kb, 474 genes), which has a genome smaller than that of any autonomously replicating cell found in nature. Synthetic bacterium JCVI-Syn3.0 retains almost all genes involved in synthesis and processing of macromolecules. Surprisingly, it also contained 149 genes with unknown biological functions, suggesting the presence of undiscovered functions essential for life. This minimal cell is a versatile platform for investigating the core functions of life, and for exploring whole‐genome design. Since it was initially reported in 2016, we have identified functions for about 50 of the original 149 genes of unknown function. These findings have been used to create flux balance analysis and kinetic whole cell computational models of our minimal cell that replicate laboratory observations about our minimal cell. Additionally, we have used JCVI-syn3.0, which has an abnormal cell division and cell morphology phenotype, and a JCVI-syn3.0 mutant containing an additional seven non-essential genes that has divides normally and looks like wild type mycoplasma mycoides to investigate how modern cell division and cell size control might have evolved. This work was supported by Synthetic Genomics, Inc., DARPA Living Foundries contract HR0011-12-C-0063, and the J. Craig Venter Institute.

J. Craig Venter 'The Dawn of Digital Life' 10/23/13

Oncology Grand Rounds: Biomarker Treatment Strategies & Emerging Therapeutic Targets - June 8, 2026

Craig Venter unveils "synthetic life"

Antineoplastic Agents | Clinical Medicine

AI has hacked the code of human civilization | Yuval Noah Harari

The MOFspace Webinar Series - Dr. Mathilde Lepoitevin

The World's Most Important Machine

TEDxConcordia - Michelle Holliday - The Pattern of Living Systems

Free Event: Power BI Beginner to Pro 2026 Edition - Full Hands-On Tutorial
100-year history of US meddling, coups and wars in the Middle East | Roy Casagranda | UNAPOLOGETIC

🩸Phlebotomy Certification Practice Test – 50 Questions to Help You PASS!

Politics Chat, June 30, 2026

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service

How to Rewire Your Brain & Learn Faster | Dr. Michael Kilgard

Introduction to Genomic Biomarkers in Radiation Oncology

mRNA COVID shots linked to blood clots? McCullough stuns Senate with explosive claims | 2025 REWIND

RL for Agents Workshop - Deep Dive on Training Agents with RL and Open Source

AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD

Billionaire's WARNING: I'm SELLING. The Crash Is Already Here!

